Nitrome Biosciences appoints Perry Karsen as Executive Chairman
– USA, CA – Nitrome Biosciences, a privately-held biopharmaceutical company developing a platform around its newly discovered class of enzymes to target Parkinson’s disease and many other age-related and inflammation disorders, today announced the appointment of Perry Karsen, a seasoned leader with 35 years of life sciences experience, as Executive Chairman of its board of directors.…